Matches in Nanopublications for { ?s ?p "[In conclusion, vandetanib might be effective in NSCLC with EGFR mutations that lack PTEN expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_assertion description "[In conclusion, vandetanib might be effective in NSCLC with EGFR mutations that lack PTEN expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1039305.RA2fHelvfyL35LXsvzFQNpDYRZJmwsRUXxL79iEc_6LVI130_provenance.